Early access: 15,549 bills from the current Congress so far, more added daily. Data from Congress.gov, GovInfo and the House and Senate vote records, updated Oct 13, 2026.
Public Law TrackerPLTPublic Law Tracker
S. 4189IntroducedSenate · nowHousePresidentLawIn committee
Sec. 1 · S. 4189

Short title; table of contents

Read this section in the full bill →

No wording changed between Introduced and Committee version.

How the text changed

Introduced · Sec. 1

(a) Short title This Act may be cited as the Improving Needed Safeguards for Users of Lifesaving Insulin Now Act of 2026 or the INSULIN Act of 2026. (b) Table of contents The table of contents for this Act is as follows: Sec. 1. Short title; table of contents. Sec. 2. Sense of Congress. TITLE I—Commercial market patient protections Sec. 101. Requirements with respect to cost-sharing for certain insulin products. Sec. 102. Application to retiree and certain small group plans. Sec. 103. Administration. TITLE II—Pharmacy benefit manager transparency and rebate reform Sec. 201. Full rebate on insulin pass-through to plan. TITLE III—Biosimilar biological product and generic drug competition and affordability Sec. 301. Ensuring timely access to generics. Sec. 302. Expediting competitive biosimilar competition. Sec. 303. Insulin competition report. TITLE IV—Programs for providing affordable insulin to uninsured individuals Sec. 401. Pilot program for providing affordable insulin to uninsured individuals. Sec. 402. GAO study on uninsured individuals who use insulin. Sec. 403. Insulin resource center and hotline for uninsured individuals.

•S 4189 ISSEC. 1
Committee version · Sec. 1

(a) Short title This Act may be cited as the Improving Needed Safeguards for Users of Lifesaving Insulin Now Act of 2026 or the INSULIN Act of 2026. (b) Table of contents The table of contents for this Act is as follows: Sec. 1. Short title; table of contents. Sec. 2. Sense of Congress. TITLE I—Commercial market patient protections Sec. 101. Requirements with respect to cost-sharing for certain insulin products. Sec. 102. Application to retiree and certain small group plans. Sec. 103. Administration. TITLE II—Pharmacy benefit manager transparency and rebate reform Sec. 201. Full rebate on insulin pass-through to plan. TITLE III—Biosimilar biological product and generic drug competition and affordability Sec. 301. Ensuring timely access to generics. Sec. 302. Expediting competitive biosimilar competition. Sec. 303. Insulin competition report. TITLE IV—Programs for providing affordable insulin to uninsured individuals Sec. 401. Pilot program for providing affordable insulin to uninsured individuals. Sec. 402. GAO study on uninsured individuals who use insulin. Sec. 403. Insulin resource center and hotline for uninsured individuals.

•S 4189 RSSEC. 1

added wordsremoved wordsComparison computed by Public Law Tracker from the official text

Sec. 1: Short title; table of contents · Public Law Tracker